MeDe Study: A Randomized Controlled Trial Comparing Median Nerve Decompression at the Carpal Tunnel Alone Versus Median Nerve Decompression at Both the Carpal Tunnel and Lacertus Fibrosis in Adults With Carpal Tunnel Syndrome
MeDe
4 other identifiers
interventional
110
1 country
2
Brief Summary
Carpal tunnel syndrome (CTS) is a condition that can cause pain, numbness, or tingling in the hand and wrist. The most common surgery for CTS is called carpal tunnel release, which aims to relieve pressure on the main nerve in the wrist. However, after this surgery, some patients (up to 4 out of 10) still have symptoms, and about 1 in 8 may need another surgery. One reason symptoms can continue is that the nerve may also be compressed higher up in the arm, near a ligament called the Lacertus fibrosus. Releasing this area might help, but it is often not checked or treated during the first surgery because current tests (like physical exams, nerve studies, and ultrasounds) cannot reliably detect it. This study is comparing two approaches for people with CTS:
- 1.Standard surgery - only releasing the carpal tunnel.
- 2.Extended surgery - releasing both the carpal tunnel and the Lacertus fibrosus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 6, 2026
CompletedFirst Submitted
Initial submission to the registry
May 11, 2026
CompletedFirst Posted
Study publicly available on registry
May 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2028
May 19, 2026
May 1, 2026
1.7 years
May 11, 2026
May 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQ SSS)
At twelve months follow-up
Secondary Outcomes (12)
BCTQ FSS
From enrollment until 12 months of follow-up
Anchor questions
At 12 months follow-up
Residual, persistent en recurrent CTS symptoms
From 6 weeks after surgery until 12 months of follow-up
Pillar pain
From 6 weeks after surgery until 12 months of follow-up
Secondary surgery
From 6 weeks until 12 months of follow-up.
- +7 more secondary outcomes
Other Outcomes (1)
Patient Demographics
At baseline
Study Arms (2)
carpal tunnel release
OTHERControl group
carpal tunnel release combined with Lacertus release
OTHERIntervention group
Interventions
Carpal tunnel release is a surgical procedure to treat carpal tunnel syndrome by cutting the ligament (transverse carpal ligament) covering the wrist's carpal tunnel. This action relieves pressure on the median nerve, alleviating pain, numbness, and weakness in the hand. It is usually an outpatient procedure done under local anesthesia.
A transverse incision is made on the forearm's volar (anterior) aspect, approximately 3cm distal of the elbow crease. This incision is placed over the palpable brachioradialis and biceps tendon. The subcutaneous tissue is dissected to expose the fascia overlying the flexor pronator muscles. The brachial fascia is identified and incised to reveal the underlying Lacertus fibrosus (also known as the bicipital aponeurosis). The Lacertus fibrosus is a tendinous band extending from the biceps tendon medially across the forearm. Care is taken to avoid injury to the underlying structures, particularly the median nerve, which lies deep and slightly medial to the Lacertus fibrosus. The Lacertus fibrosus is incised transversely. The surgeon ensures that the median nerve is fully decompressed and that there are no remaining constrictive bands. It is usually an outpatient procedure done under local anesthesia.
Eligibility Criteria
You may qualify if:
- Patients being at least 18 years or older
- CTS confirmed by EMG or nerve ultrasound
- Patient opts for surgical treatment
You may not qualify if:
- Previous surgical decompression of the median nerve at the ipsilateral wrist or forearm
- Severe thenar atrophy: Examination of the thenar is based on clinical observation. The presence of thenar muscle atrophy is scored as none, mild, or severe.
- Simultaneous nerve decompression in the ipsilateral arm (e.g. cubital tunnel, Guyon and radial nerve release.
- Neurological disorders affecting peripheral nerves (e.g. spinal cord compression or injury, muscular dystrophy, dystonia, ALS)
- Malunion of the distal radius
- Impaired hand function
- Pregnancy
- Inability to complete study forms due to insufficient comprehension of the Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Maasstad Ziekenhuis
Rotterdam, South Holland, 3079 DZ, Netherlands
Spijkenise Medisch Centrum
Rotterdam, South Holland, 3201 GZ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Sebastian Poggio Voormolen, BSc, PhD candidate
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 11, 2026
First Posted
May 19, 2026
Study Start
May 6, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2028
Last Updated
May 19, 2026
Record last verified: 2026-05